Muzammil L. Dastagir

Internal Medicine

2105 E South Blvd
Montgomery, AL 36116

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

HSR26-201: Prognostic Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality.

HSR26-201: Prognostic Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality.

HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Neoadjuvant Alectinib in a Patient With Anaplastic Lymphoma Kinase (ALK)-Mutant Stage III Lung Adenocarcinoma: A Case Report.

Neoadjuvant Alectinib in a Patient With Anaplastic Lymphoma Kinase (ALK)-Mutant Stage III Lung Adenocarcinoma: A Case Report.

Journal: Cureus

Published: October 24, 2025

Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model.

Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model.

Journal: Molecular and cellular biochemistry

Published: July 12, 2022

Showing 1-4 of 4

Last Updated: 09/26/2026